Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
about
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameTransitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decadesEstablishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology.Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetesEzetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver diseaseAltered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD).Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review.Cardiometabolic diseases and related complications: current status and future perspective.Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver BiopsiesExtracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH.Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial.
P2860
Q26775571-F42C834D-568B-48EF-A463-5465A6FC959BQ28088798-5A07FCD2-0F09-4EEE-B00F-A96DBDE7BA23Q34764818-DBD7BBA6-7775-4C3B-9EEF-3BCFFC3FBD74Q34785324-E3D879AB-72AC-426E-B51A-6587513CD111Q35048289-45AD4C00-6186-4BFB-A5D3-EA4781BA0843Q35550630-8F397672-35CE-4985-BF5F-67E6ABEB4382Q35783896-478A8534-2605-49D2-AB34-D48F9AC03748Q38175368-931836D7-E740-440E-83FF-7B32340BC5C4Q38657709-045D0243-DACF-42E1-B8FC-832416BF29A0Q39316263-49702F52-379B-4350-8A77-53613E086ECEQ41783506-6247F5BD-E004-4D2B-A614-F32174C1E083Q42033362-E78CD261-B6F5-435C-A694-97EE736F9DD4Q47581786-275901A7-FE40-4FD9-97F6-A803F9C37C0CQ47584564-390A5554-16AF-47BB-B825-4106613723B3Q55175731-E6DD9532-2C50-48BB-A676-5D6D75DAD7CC
P2860
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@en
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@nl
type
label
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@en
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@nl
prefLabel
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@en
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@nl
P2860
P356
P1476
Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
@en
P2093
Carolin Lackner
P2860
P304
P356
10.1586/EGH.11.8
P577
2011-04-01T00:00:00Z